Bluetongue virus recombinant vaccines and uses thereof

Details for Australian Patent Application No. 2011224188 (hide)

Owner Biolex Therapeutics Merial Limited

Inventors Audonnet, Jean-Christophe; Guo, Xuan; Cox, Kevin

Agent FB Rice

Pub. Number AU-A-2011224188

PCT Pub. Number WO2011/112955

Priority 61/313,164 12.03.10 US; 61/366,363 21.07.10 US

Filing date 11 March 2011

Wipo publication date 15 September 2011

International Classifications

C07K 14/14 Peptides having more than 20 amino acids

A61K 39/15 Medicinal preparations containing antigens or antibodies - Reoviridae, e.g. calf diarrhea virus

C12N 15/82 Mutation or genetic engineering - for plant cells

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/112955 Priority application(s): WO2011/112955

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224190-Query model over information as a networked service

2011224186-Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers